Aardvark Therapeutics AARD
NASDAQ AARD
$5.45 +0.18 (+3.63%)
As of: Oct 2, 2026 · 9:51 AM EDT

Aardvark Therapeutics (AARD) Return on Assets [ROA] (2025 - 2026)

Updated

Aardvark Therapeutics (AARD) reported Return on Assets [ROA] of -77.64% for Q2 2026, down 53.68 percentage points from -23.96% a year earlier and down 12.88 percentage points from the prior quarter.

Analysis

Aardvark Therapeutics (AARD) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Aardvark Therapeutics posted Return on Assets [ROA] of -59.16%.

  • Per Business Quant data, the three quarters before Q2 2026 came in at -64.76% (Q1 2026), -45.99% (Q4 2025) and -34.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Aardvark Therapeutics 115.33 Mn 41.43 Mn - -77.64%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -77.64%
Mar 31, 2026 -64.76%
Dec 31, 2025 -45.99%
Sep 30, 2025 -34.73%
Jun 30, 2025 -23.96%
Mar 31, 2025 -23.53%
API Access

Aardvark Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AARD&period=max&api_key=YOUR_API_KEY